KMT2C c.9147_9148insT ;(p.E3050*)

Variant ID: 7-151873390-C-CA

NM_170606.2(KMT2C):c.9147_9148insT;(p.E3050*)

This variant was identified in 1 publication

View GRCh38 version.




Publications:


CXCL10 potentiates immune checkpoint blockade therapy in homologous recombination-deficient tumors.

Theranostics
Shi, Zhiwen Z; Shen, Jianfeng J; Qiu, Junjun J; Zhao, Qingguo Q; Hua, Keqin K; Wang, Hongyan H
Publication Date: 2021

Variant appearance in text: N/A
PubMed Link: 34158843
Variant Present in the following documents:
View BVdb publication page